C

CorMedix
D

CRMD

11.150
USD
2.14
(23.75%)
قبل الجلسة
حجم التداول
10
الربح لكل سهم
1
العائد الربحي
-
P/E
-37
حجم السوق
756,086,807
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 7 أشهر
buy
2024-10-03 08:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
-0.14000
(-4.53%)
2.95000 USD
A
AKBA
-0.00500
(-0.21%)
2.32500 USD
C
CLRB
-0.02680
(-10.04%)
0.24020 USD
D
DVAX
-0.350
(-3.11%)
10.905 USD
M
MDGL
-11.37
(-3.71%)
295.00 USD
R
RDHL
-0.19500
(-9.31%)
1.90000 USD
R
RMTI
-0.08500
(-7.17%)
1.10000 USD
S
SNDX
-2.950
(-21.77%)
10.600 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.